Drospirenone in combination with estrogens: for contraception and hormone replacement therapy

@article{Oelkers2005DrospirenoneIC,
  title={Drospirenone in combination with estrogens: for contraception and hormone replacement therapy},
  author={W. Oelkers},
  journal={Climacteric},
  year={2005},
  volume={8},
  pages={19 - 27}
}
Progesterone has a high affinity for the mineralocorticoid receptor and is an antagonist of aldosterone. Almost all synthetic progestogens are devoid of an antimineralocorticoid effect, and are unable to antagonize the salt-retaining effect of estrogens. This property could be one cause of the weight gain and increase in blood pressure associated with the use of combined oral contraceptives and, in some susceptible women, with postmenopausal hormone replacement therapy (HRT). This review… Expand
The use of newer progestins for contraception.
Drospirenone, a progestin with a unique cardiovascular profile, for safe contraception and treatment of menopausal symptoms
  • O. Ylikorkala
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2005
A review of the cardiovascular and breast actions of drospirenone in preclinical studies
Drospirenone: an antihypertensive in waiting.
Drospirenone: a novel progestin
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 24 REFERENCES
Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone.
  • W. Oelkers
  • Medicine
  • The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 2002
Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties.
  • A. Rübig
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2003
Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol
  • P. Rosenbaum, W. Schmidt, +7 authors R. Heithecker
  • Medicine
  • The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 2000
Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.
...
1
2
3
...